BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

905 related articles for article (PubMed ID: 10683323)

  • 1. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR; Yang L; Voytek C; Margolis TP
    Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia.
    Maggioncalda J; Mehta A; Su YH; Fraser NW; Block TM
    Virology; 1996 Nov; 225(1):72-81. PubMed ID: 8918535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice.
    Ghiasi H; Perng G; Nesburn AB; Wechsler SL
    Microb Pathog; 1999 Dec; 27(6):387-94. PubMed ID: 10588911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis.
    Branco FJ; Fraser NW
    J Virol; 2005 Jul; 79(14):9019-25. PubMed ID: 15994795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1.
    Halford WP; Gebhardt BM; Carr DJ
    J Immunol; 1996 Oct; 157(8):3542-9. PubMed ID: 8871654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-consensus branch point plays an important role in determining the stability of the 2-kb LAT intron during acute and latent infections of herpes simplex virus type-1.
    Mukerjee R; Kang W; Suri V; Fraser NW
    Virology; 2004 Jul; 324(2):340-9. PubMed ID: 15207620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricted herpes simplex virus type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes.
    Gesser RM; Valyi-Nagy T; Fraser NW
    Virology; 1994 May; 200(2):791-5. PubMed ID: 8178461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An HSV-1 containing the rat beta-glucuronidase cDNA inserted within the LAT gene is less efficient than the parental strain at establishing a transcriptionally active state during latency in neurons.
    Deshmane SL; Valyi-Nagy T; Block T; Maggioncalda J; Wolfe JH; Dillner A; Fraser NW
    Gene Ther; 1995 May; 2(3):209-17. PubMed ID: 7614252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons.
    Valyi-Nagy T; Olson SJ; Valyi-Nagy K; Montine TJ; Dermody TS
    Virology; 2000 Dec; 278(2):309-21. PubMed ID: 11118355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
    Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
    Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.
    Kovacs SK; Tiwari V; Prandovszky E; Dosa S; Bacsa S; Valyi-Nagy K; Shukla D; Valyi-Nagy T
    Curr Eye Res; 2009 Oct; 34(10):896-904. PubMed ID: 19895317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1.
    Halford WP; Gebhardt BM; Carr DJ
    Virology; 1997 Nov; 238(1):53-63. PubMed ID: 9375008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate and acquired immunity to herpes simplex virus type 1.
    Halford WP; Veress LA; Gebhardt BM; Carr DJ
    Virology; 1997 Sep; 236(2):328-37. PubMed ID: 9325240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An M2 Rather than a T
    Lee DH; Ghiasi H
    J Virol; 2018 May; 92(10):. PubMed ID: 29491152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral inoculation of SCID mice with an attenuated herpes simplex virus-1 strain causes persistent enteric nervous system infection and gastric ulcers without direct mucosal infection.
    Gesser RM; Valyi-Nagy T; Fraser NW; Altschuler SM
    Lab Invest; 1995 Dec; 73(6):880-9. PubMed ID: 8558851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation.
    Chen SH; Garber DA; Schaffer PA; Knipe DM; Coen DM
    Virology; 2000 Dec; 278(1):207-16. PubMed ID: 11112495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E modulates establishment of HSV-1 latency and survival in a mouse ocular model.
    Bhattacharjee PS; Neumann DM; Stark D; Thompson HW; Hill JM
    Curr Eye Res; 2006 Sep; 31(9):703-8. PubMed ID: 16966142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
    Vollstedt S; Franchini M; Alber G; Ackermann M; Suter M
    J Virol; 2001 Oct; 75(20):9596-600. PubMed ID: 11559791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
    Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
    J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.